Inhibitors of the hedgehog pathway

The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Fo...

Full description

Saved in:
Bibliographic Details
Main Authors MARLOWE CHARLES K, TAKEUCHI CRAIG STACY, BAJJALIEH WILLIAM, KIM BYUNG GYU, WANG YONG, FORSYTH TIMOTHY PATRICK, MANN GRACE, SHI XIAN, LEAHY JAMES W, CHEN JEFF, MAC MORRISON B, HUYNH TAI PHAT, LEWIS GARY L, RIDGWAY BRIAN HUGH, SANGALANG JOAN C, LEE MATTHEW SANGYUP, EPSHTEYN SERGEY, BAHCECI SULEYMAN
Format Patent
LanguageEnglish
Published 05.08.2014
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
CHEMISTRY
FISHING
FORESTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEST REPELLANTS OR ATTRACTANTS
PLANT GROWTH REGULATORS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF
TRAPPING
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Formula I to treat cancer.
Bibliography:Application Number: US201213487559